Deep Blue Biotech
Founded 2023 · 6 employees on LinkedIn · 3 known investors
Find your way into Deep Blue Biotech
120 people in our graph share verified history with the Deep Blue Biotech team — schools, employers, funds. One of them is your warm intro.
Drew Burdonunlockedknows Tim Corcoran · together at University of Leicester (overlapped)
×8knows the team · via University of Leicester
knows the team · via Coderhouse
knows the team · via Universitat Autònoma de Barcelona
knows the team · via Universidad Nacional de Rosario
Deep Blue Biotech develops sustainable chemicals by re-engineering cyanobacteria to convert CO₂ into high-value molecules, using AI-driven metabolic modelling. Its products include an ocean-derived hyaluronic acid, targeting the cosmetics/ingredients and broader chemicals industry.
Founders & leadership
TC
Tim CorcoraninChief Executive OfficerTim Corcoran has held commercial and leadership positions over 25 years across multiple sectors, including established international corporations and early-stage companies, before becoming CEO of Deep Blue Biotech.
LB
Lucia BurdissoinChief Scientific OfficerLucia Burdisso holds a PhD in biotechnology and brings over 10 years of R&D experience across academic institutions and biotech startups, with background in assay development, strain engineering, and photosynthetic bioproduction. As Chief Scientific Officer at Deep Blue Biotech, she leads the scientific strategy for the company's cyanobacterial synthetic biology platform.
MR
Manuel RiosinChair of Innovation
Investors · 3
Frequently asked questions
- What does Deep Blue Biotech do?
- Deep Blue Biotech develops sustainable chemicals by re-engineering cyanobacteria to convert CO₂ into high-value molecules, using AI-driven metabolic modelling. Its products include an ocean-derived hyaluronic acid, targeting the cosmetics/ingredients and broader chemicals industry.
- Who are Deep Blue Biotech's investors?
- Deep Blue Biotech's investors include Carbon13, One Planet Capital, Sustainable Ventures.